Tiberend Strategic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tiberend strategic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tiberend Strategic Today - Breaking & Trending Today

BioEclipse to Participate in Biotech Showcase Digital During "J.P. Morgan Week 2021"


During Biotech Showcase Digital, registered conference participants will be able to watch a pre-recorded presentation by BioEclipse. Also, Dr. Contag will host virtual one-on-one meetings with registered investors and pharmaceutical and biotechnology companies via the conference s networking and scheduling platform, partneringONE®, to discuss BioEclipse s business and  highlight recent corporate achievements, as well as anticipated milestones in the clinical program for CRX100. BioEclipse has initiated an open-label, Phase 1 dose-escalation study to evaluate the safety, tolerability, and pharmacokinetic (PK) properties of CRX100 in advanced solid tumors that do not respond to standard of care, including triple-negative breast cancer, colorectal cancer, hepatocellular carcinoma, osteosarcoma, epithelial ovarian cancer, and gastric cancer. ....

Pam Contag , Miriam Miller , Stanford University , Eclipse Therapeutics , Biotech Showcase Digital , Biotech Showcase , Tiberend Strategic , Bioeclipse Therapeutics , மிரியம் மில்லர் , ஸ்டான்போர்ட் பல்கலைக்கழகம் , கிரகணம் சிகிச்சை , பயோடெக் காட்சி பெட்டி டிஜிட்டல் , பயோடெக் காட்சி பெட்டி ,